In-vivo studies of the action spectrum and time course for release of transforming growth factor-alpha by ultraviolet irradiation in man.
Transforming growth factor-alpha (TGF-alpha) is a growth-promoting cytokine which enhances epithelial proliferation and is secreted by a wide variety of tumour cells. It is also present in normal human epidermis and its overproduction may be responsible for epidermal hyperproliferation in psoriasis. Ultraviolet (UV) B irradiation of human skin leads to epidermal damage and significant subsequent hyperplasia after approximately 24 h, whereas UVA irradiation has little such effect and predominantly damages the dermis. The relative efficacies of UVB and UVA in releasing TGF-alpha were studied in 10 subjects of skin types I and II using a skin-chamber technique and a specific TGF-alpha radioimmunoassay. Significantly elevated concentrations of immunoreactive TGF-alpha were detected in samples after 24 h in UVB-irradiated compared with unirradiated skin. Samples at earlier time points from UVB- and UVA-exposed skin contained measurable levels of TGF-alpha but these were not significantly elevated above the levels found in samples from unirradiated areas. These results, which suggest the UVB irradiation increases release of TGF-alpha from human skin at 24 h, indicate that TGF-alpha may be implicated in UVB-induced epidermal hyperplasia.
Murphy
G M
GM
Institute of Dermatology, St Thomas' Hospital, London, U.K.
Quinn
D G
DG
Camp
R D
RD
Hawk
J L
JL
Greaves
M W
MW
D002455:Cell Division / Q000528:radiation effects; D004817:Epidermis / Q000378:metabolism / Q000528:radiation effects*; D006801:Humans; D011863:Radioimmunoassay; D013997:Time Factors; D016211:Transforming Growth Factor alpha / Q000096:biosynthesis*; D014466:Ultraviolet Rays / Q000009:adverse effects*
D016211:Transforming Growth Factor alpha